FDA Inspection 1038093 — Somerset Therapeutics Private Limited

Somerset Therapeutics Private Limited — FEI 3003821988

The FDA completed an inspection of Somerset Therapeutics Private Limited on December 5, 2017 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 5, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)